WRENN CAROL 4
4 · ALPHARMA INC · Filed Feb 2, 2007
Insider Transaction Report
Form 4
ALPHARMA INCALO
WRENN CAROL
President, Animal Health
Transactions
- Sale
Common Stock A
2007-02-01$28.00/sh−7,000$196,000→ 24,063 total - Sale
Common Stock A
2007-02-01$28.00/sh−5,000$140,000→ 24,063 total - Exercise/Conversion
Common Stock A
2007-02-01$9.48/sh+7,000$66,360→ 31,063 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2007-02-01−5,000→ 0 totalExercise: $14.44Exp: 2012-04-02→ Common Stock A (5,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2007-02-01−30,000→ 0 totalExercise: $23.92Exp: 2011-11-26→ Common Stock A (30,000 underlying) - Sale
Common Stock A
2007-02-01$28.00/sh−30,000$840,000→ 24,063 total - Exercise/Conversion
Common Stock A
2007-02-01$14.44/sh+5,000$72,185→ 29,063 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2007-02-01−7,000→ 0 totalExercise: $9.48Exp: 2012-10-31→ Common Stock A (7,000 underlying) - Exercise/Conversion
Common Stock A
2007-02-01$23.92/sh+30,000$717,660→ 54,063 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]These options become exercisable at a rate of 25% on each of the four anniversary dates immediately following the date of grant.